Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients-Reference-Cited by-同舟云学术

Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients

Published:2014-07-23 Issue:246 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Sherman Kenneth E.¹,Guedj Jeremie²³,Shata Mohamed Tarek¹,Blackard Jason T.¹,Rouster Susan D.¹,Castro Mario⁴,Feinberg Judith¹,Sterling Richard K.⁵,Goodman Zachary⁶,Aronow Bruce J.⁷,Perelson Alan S.²

Affiliation:

1. University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

2. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.

3. Institut National de la Santé et de la Recherche Médicale and Université Paris Diderot, Sorbonne Paris Cité, Unité Mixte de Recherche, Paris 75013, France.

4. Escuela Técnica Superior de Ingeniería, Universidad Pontificia Comillas, 28015 Madrid, Spain.

5. Virginia Commonwealth University, Richmond, VA 23284, USA.

6. Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA 22042, USA.

7. Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.

Abstract

Treatment of HIV patients co-infected with hepatitis C virus (HCV) with HIV antiretroviral drug therapy reduces HCV replication.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference37 articles.

1. Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

2. Human immunodeficiency virus and liver disease forum 2010: Conference proceedings

3. Drug-Induced Liver Injury Associated with Antiretroviral Therapy that Includes HIV-1 Protease Inhibitors

4. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections

5. Patients co‐infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causes and outcomes of hepatic fibrosis in persons living with HIV;Current Opinion in HIV and AIDS;2022-09-12

2. Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam;AIDS Research and Human Retroviruses;2022-01-13

3. Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication;AIDS;2021-10-25

4. Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity;Heliyon;2021-06

5. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro;PLOS ONE;2019-10-29